Evidence map›Paper›PMID 30767829›Full record

ArticleInfection control and hospital epidemiology2019

Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.

Larry K Kociolek, Preeta K Kutty, Philip M Polgreen, Susan E Beekmann

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Microorganisms · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Larry K KociolekDepartment of Pediatrics,Northwestern University Feinberg School of Medicine,Chicago, Illinois.ORCID 0000-0002-8756-3417
Preeta K KuttyDivision of Healthcare Quality Promotion,National Center for Emerging and Zoonotic Infectious Diseases,Centers for Disease Control and Prevention, Atlanta, Georgia.
Philip M PolgreenDepartment of Internal Medicine,University of Iowa Carver College of Medicine,Iowa City, Iowa.
Susan E BeekmannDepartment of Internal Medicine,University of Iowa Carver College of Medicine,Iowa City, Iowa.
University of Iowa · USCenters for Disease Control and Prevention · USNorthwestern University · US

Funding

Optimizing the diagnosis of pediatric Clostridium difficile infectionK23AI123525 · NIAID · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI KOCIOLEK, LARRY K · 2016 to 2020
$937k
NIAID NIH HHS K23 AI123525NIAID NIH HHS L40 AI106713
6 · The paper itself

Abstract

objectiveTo characterize healthcare provider diagnostic testing practices for identifying Clostridioides (Clostridium) difficile infection (CDI) and asymptomatic carriage in children.

designElectronic survey.

methodsAn 11-question survey was sent by e-mail or facsimile to all pediatric infectious diseases (PID) members of the Infectious Diseases Society of America's Emerging Infections Network (EIN).

resultsAmong 345 eligible respondents who had ever responded to an EIN survey, 196 (57%) responded; 162 of these (83%) were aware of their institutional policies for CDI testing and management. Also, 159 (98%) respondents knew their institution's C. difficile testing method: 99 (62%) utilize NAAT without toxin testing and 60 (38%) utilize toxin testing, either as a single test or a multistep algorithm. Of 153 respondents, 10 (7%) reported that formed stools were tested for C. difficile at their institution, and 76 of 151 (50%) reported that their institution does not restrict C. difficile testing in infants and young children. The frequency of symptom- and age-based testing restrictions did not vary between institutions utilizing NAAT alone compared to those utilizing toxin testing for C. difficile diagnosis. Of 143 respondents, 26 (16%) permit testing of neonatal intensive care unit patients and 12 of 26 (46%) treat CDI with antibiotics in this patient population.

conclusionsThese data suggest that there are opportunities to improve CDI diagnostic stewardship practices in children, including among hospitals using NAATs alone for CDI diagnosis in children.

Indexed as

Antimicrobial StewardshipAsymptomatic InfectionsChildChild HealthChild, PreschoolClostridioides difficileClostridium InfectionsCommunicable Diseases, EmergingDiagnostic Tests, RoutineHumansInfantNucleic Acid Amplification TechniquesSurveys and Questionnaires

Identifiers

PMID30767829
PMCPMC6934170
OpenAlexW2912550417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.